首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Pretransplant serum ferritin level may be a?predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
【24h】

Pretransplant serum ferritin level may be a?predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.

机译:移植前血清铁蛋白水平可能是异基因造血干细胞移植患者预后的预测指标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Iron overload increases the risk of infections, veno-occlusive disease and hepatic dysfunction in post-transplant period. Our objective was to investigate the association of pre-transplant ferritin levels with complications and survival after allogeneic hematopoietic stem cell transplantation (alloHSCT).We retrospectively analysed 84 patients' data who had undergone allogeneic HSCT into two groups: patients with a?serum ferritin level≥1000ng/ml, and patients with <1000?ng/ml at the time of HSCT.Cox-regression analysis showed that pre-transplant serum ferritin levels were significantly higher in patients who had at least one infectious event compared with those who had no any infectious event in the post-transplant 100 days (p<0.023). Overall survival (OS) and disease-free survival (DFS) rates were significantly higher in patients with a?time-to-tx interval 12 months (p=0.002 and p=0.008 respectively). A?higher risk of death was observed in high-ferritin group (hazard ratio=2.27, CI:1.01-5.09, p=0.023 for OS and hazard ratio=2.49, CI:1.12-5.53 p=0.039 for DFS). No significant effect on OS and DFS among groups was observed for variables conditioning regimen, gender and diagnosis. Acute GVHD was more common in patients with a?ferritin level ≥1000 ng /mL, but this was not statistically significant (p>0.05). There was no statistical significance in both groups (ferritin≥1000ng /mL and ferritin0.05). Platelet and neutrophil engaftment day was not found statistically significant compared with both groups (p=0.273 and p=0.882, respectively).Pre-transplant ferritin levels may predict poor outcomes in patients who had undergone allogeneic hematopoietic stem cell transplantation. Keywords: allogeneic hematopoietic stem cell transplantation, ferritin, graft-versus-host disease, iron overload, survival.
机译:铁超载会增加移植后感染,静脉闭塞性疾病和肝功能障碍的风险。我们的目的是研究异基因造血干细胞移植(alloHSCT)后移植前铁蛋白水平与并发症和存活的关系。我们回顾性分析了84例接受异基因HSCT的患者数据,分为两组:血清铁蛋白水平患者≥1000ng/ ml且HSCT时<1000?ng / ml的患者。Cox回归分析显示,至少有一次感染的患者与未感染的患者相比,移植前血清铁蛋白水平显着更高移植后100天内的任何传染性事件(p <0.023)。间隔时间为12个月的患者的总生存(OS)和无病生存(DFS)率显着更高(分别为p = 0.002和p​​ = 0.008)。在高铁蛋白组中观察到更高的死亡风险(OS的危险比= 2.27,CI:1.01-5.09,p = 0.023,DFS的危险比= 2.49,CI:1.12-5.53 p = 0.039)。在条件调节方案,性别和诊断方面,未观察到对OS和DFS的显着影响。铁蛋白水平≥1000ng / mL的患者中急性GVHD更为常见,但无统计学意义(p> 0.05)。两组均无统计学意义(铁蛋白≥1000ng/ mL,铁蛋白0.05)。与两组相比,血小板和中性粒细胞的融合日均无统计学意义(分别为p = 0.273和p = 0.882)。移植前铁蛋白水平可能预示着异基因造血干细胞移植患者的预后不良。关键词:同种异体造血干细胞移植,铁蛋白,移植物抗宿主病,铁超负荷,存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号